Ronac Mamtani, MD, MSCE

faculty photo
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-308
3400 Civic Center Blvd
Philadelphia, PA 19147
Office: 2156627606
Fax: (215) 349-8551
Education:
BS
Cornell University, 2002.
MD (Internal Medicine)
Stony Brook School of Medicine, 2006.
MS (Clinical Epidemiology)
University of Pennsylvania , 2012.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Ravi B. Parikh, Eun Jeong Min, E. Paul Wileyto, Fauzia Riaz, Cary P Gross, Roger B. Cohen, Rebecca A. Hubbard, Qi Long, Ronac Mamtani: Uptake and Survival Outcomes Following Immune Checkpoint Inhibitor Therapy Among Trial Ineligible Patients with Advanced Solid Cancers. JAMA Onc Nov 2021.

Frank I Scott, Amneet K Hans, Mark E Gerich, Blair Fennimore, Ronac Mamtani, Ravy K Vajravelu, James D Lewis: Identification of the Most Effective Position for Ustekinumab in Treatment Algorithms for Crohn's Disease. Clin Gastroenterol Hepatol Oct 2021.

Amélie Wetzman, Cédric Lukas, Cécile Gaujoux-Viala, Ronac Mamtani, Thomas Barnetche, Bernard Combe, Jacques Morel, Paulina Szafors: Risk of cancer after initiation of targeted therapies in patients with rheumatoid arthritis and a prior cancer: systematic review with meta-analysis. Arthritis Care Res Sept 2021.

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, Nobuaki Matsubara, Lajos Géczi, Susanna Y-S Cheng, Yves Fradet, Stephane Oudard, Christof Vulsteke, Rafael Morales Barrera, Aude Fléchon, Seyda Gunduz, Yohann Loriot, Alejo Rodriguez-Vida, Ronac Mamtani, Evan Y Yu, Kijoeng Nam, Kentaro Imai, Blanca Homet Moreno, Ajjai Alva, KEYNOTE-361 Investigators: Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial. Lancet Oncol. Jul 2021.

Kelsey S. Lau-Min, Yimei Li,Jennifer R. Eads, Xiaoliang Wang, Neal J. Meropol, Ronac Mamtani*, and Kelly D. Getz*: Adherence to and Determinants of Guideline-Recommended Biomarker Testing and Targeted Therapy in Patients With Gastroesophageal Adenocarcinoma: Insights From Routine Practice. Cancer Jul 2021 Notes: *Denotes equal contribution.

Erin M Bange, Nicholas A Han, Paul Wileyto, Justin Y Kim, Sigrid Gouma, James Robinson, Allison R Greenplate, Madeline A Hwee, Florence Porterfield, Olutosin Owoyemi, Karan Naik, Cathy Zheng, Michael Galantino, Ariel R Weisman, Caroline A G Ittner, Emily M Kugler, Amy E Baxter, Olutwatosin Oniyide, Roseline S Agyekum, Thomas G Dunn, Tiffanie K Jones, Heather M Giannini, Madison E Weirick, Christopher M McAllister, N Esther Babady, Anita Kumar, Adam J Widman, Susan DeWolf, Sawsan R Boutemine, Charlotte Roberts, Krista R Budzik, Susan Tollett, Carla Wright, Tara Perloff, Lova Sun, Divij Mathew, Josephine R Giles, Derek A Oldridge, Jennifer E Wu, Cécile Alanio, Sharon Adamski, Alfred L Garfall, Laura A Vella, Samuel J Kerr, Justine V Cohen, Randall A Oyer, Ryan Massa, Ivan P Maillard, Kara N Maxwell, John P Reilly, Peter G Maslak, Robert H Vonderheide, Jedd D Wolchok, Scott E Hensley, E John Wherry, Nuala J Meyer, Angela M DeMichele, Santosha A Vardhana*, Ronac Mamtani*, Alexander C Huang* : CD8 + T cells contribute to survival in patients with COVID-19 and hematologic cancer. Nat Med Jul 2021 Notes: *Denotes equal contribution.

Mamtani R, Lund J, Hubbard RA: Considering the totality of evidence: Combining real‐world data with clinical trial results to better inform decision‐making. Pharmacoepidemiology and Drug Safety Jun 2021.

Joanna Harton, Ronac Mamtani, Nandita Mitra, Rebecca A Hubbard: Bias Reduction Methods for Propensity Scores Estimated from Error-Prone EHR-Derived Covariates. Health Serv Outcomes Res Methodol Jun 2021.

Ronac Mamtani, Jonathan E. Rosenberg, Thomas Powles, Guru P. Sonpavde, Yohann Loriot, Ignacio Duran, Jae-Lyun Lee, Nobuaki Matsubara, Christof Vulsteke, Daniel Castellano, Srikala S. Sridhar, Helle Pappot, Begoña P. Valderrama, Howard Gurney, Jens Bedke, Michiel Simon Van Der Heijden, Chunzhang Wu, Zsolt Hepp, Caroline McKay, Daniel P. Petrylak: Quality of life, functioning, and symptoms in patients with previously treated locally advanced or metastatic urothelial carcinoma from EV-301: A randomized phase 3 trial of enfortumab vedotin versus chemotherapy. merican Society for Clinical Oncology Annual Meeting Jun 2021 Notes: Poster Oral Presentation.

Lova Sun, Sanjna Surya, Noah G Goodman, Anh N Le, Gregory Kelly, Olutosin Owoyemi, Heena Desai, Cathy Zheng, Shannon DeLuca, Madeline L Good, Jasmin Hussain, Seth D Jeffries, Yolanda R Kry, Emily M Kugler, Maikel Mansour, John Ndicu, AnnaClaire Osei-Akoto, Timothy Prior, Stacy L Pundock, Lisa A Varughese, JoEllen Weaver, Abigail Doucette, Scott Dudek, Shefali Setia Verma, Sigrid Gouma, Madison E Weirick, Christopher M McAllister, Erin Bange, Peter Gabriel, Marylyn Ritchie, Daniel J Rader, Robert H Vonderheide, Lynn M Schuchter, Anurag Verma, Ivan Maillard, Ronac Mamtani, Scott E Hensley , Robert Gross, E Paul Wileyto, Alexander C Huang, Kara N Maxwell, Angela DeMichele: SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed Therapy. JCO Oncol Pract Jun 2021.

back to top
Last updated: 10/21/2021
The Trustees of the University of Pennsylvania